Managers

GreenSky’s IPO and the second wave of fintech offerings

Team 8 to raise $85 mln cybersecurity venture fund

Team 8 has set out to raise an $85 million second cybersecurity-focused venture-capital fund, according to a filing with the SEC.

Innovation Endeavors raises $333.5 mln for third fund

Innovation Endeavors has raised $333.5 million for its third fund, according to an SEC filing. With offices in Palo Alto, Tel Aviv and New York City, Innovation Endeavors invests in "visionary founders, transformational technology and emergent ecosystems for a new world."

Luma Health nets $6.33 mln Series A

Luma Health, a provider of smart patient-provider communications, has closed $6.33 million in Series A funding. U.S. Venture Partners led the round with participation from other investors that included Stanford-StartX Fund. In addition to the funding, Dafina Toncheva of U.S. Venture Partners will join Luma Health's board of directors.

Iora Health racks up $100 mln Series E

Boston-based Iora Health, a primary care provider with a focus on Medicare patients over 65 years of age, has secured $100 million in Series E funding. The investors included .406 Ventures, Devonshire Investors, F-Prime Capital, Flare Capital Partners, GE Ventures, Humana, Khosla Ventures, Polaris Partners and Temasek.

KdT Ventures wraps up maiden fund

KdT Ventures, an early-stage venture firm focused on the intersection of technology and science, has closed its debut fund. No financial terms were disclosed. The fund's limited partners include institutional investment firms.

Ally Bridge Group leads $300 mln round for GRAIL

GRAIL Inc, a healthcare company focused on detecting cancer early, has secured $300 million in Series C funding. The lead investor was Ally Bridge Group.

Insightin Health nabs $2 mln

Insightin Health, a provider of an AI-driven decision platform that helps health insurance companies with preventative actions for their members, has raised $2 million in financing round. Health Catalyst Capital Management led the round with participation from other investors that included Revolution's Rise of the Rest Seed Fund, TEDCO, SaaS Ventures and TCP Ventures.

Canopy Biosciences takes in $2.4 mln Series A

St. Louis, Missouri-based Canopy Biosciences, a research tools company focusing on gene editing and expression analysis, has raised $2.4 million in Series A funding. BioGenerator, the investment arm of BioSTL, and Kingdom Capital led the round.

Tear Film Innovations fetches $8.5 mln

Carlsbad, California-based Tear Film Innovations Inc, a maker of the iLux evaporative dry eye system, has secured $8.5 million in funding. Visionary Ventures and Bluestem Capital led the round.